Gene · 1846
Papers1,689
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,689
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Capicua (CIC) mutations in gliomas in association with MAPK activation for exposing a potential therapeutic target. | Med Oncol | 2023 | 37291277 | PubTator, text mining | PubMed |
| Targeting CXCR4 abrogates resistance to trastuzumab by blocking cell cycle progression and synergizes with docetaxel in breast cancer treatment. | Breast Cancer Res | 2023 | 37280713 | PubTator, text mining | PubMed |
| Group A Streptococcus induces CD1a-autoreactive T cells and promotes psoriatic inflammation. | Sci Immunol | 2023 | 37267382 | PubTator, text mining | PubMed |
| Defining function of wild-type and three patient-specific TP53 mutations in a zebrafish model of embryonal rhabdomyosarcoma. | Elife | 2023 | 37266578 | PubTator, text mining | PubMed |
| Transcriptional coactivation by EHMT2 restricts glucocorticoid-induced insulin resistance in a study with male mice. | Nat Commun | 2023 | 37253782 | PubTator, text mining | PubMed |
| Signaling Switching from Hedgehog-GLI to MAPK Signaling Potentially Serves as a Compensatory Mechanism in Melanoma Cell Lines Resistant to GANT-61. | Biomedicines | 2023 | 37239024 | PubTator, text mining | PubMed |
| A T-cell-related signature for prognostic stratification and immunotherapy response in hepatocellular carcinoma based on transcriptomics and single-cell sequencing. | BMC Bioinformatics | 2023 | 37231356 | PubTator, text mining | PubMed |
| Integration of multiomics data shows down regulation of mismatch repair and tubulin pathways in triple-negative chemotherapy-resistant breast tumors. | Breast Cancer Res | 2023 | 37226243 | PubTator, text mining | PubMed |
| New insights into signal transduction pathways in adrenal steroidogenesis: role of mitochondrial fusion, lipid mediators, and MAPK phosphatases. | Front Endocrinol (Lausanne) | 2023 | 37223023 | PubTator, text mining | PubMed |
| ScRNA-seq revealed an immunosuppression state and tumor microenvironment heterogeneity related to lymph node metastasis in prostate cancer. | Exp Hematol Oncol | 2023 | 37221625 | PubTator, text mining | PubMed |
| Fibronectin Contributes to a BRAF Inhibitor-driven Invasive Phenotype in Thyroid Cancer through EGR1, Which Can Be Blocked by Inhibition of ERK1/2. | Mol Cancer Res | 2023 | 37219859 | PubTator, text mining | PubMed |
| Phenotypic diversity of T cells in human primary and metastatic brain tumors revealed by multiomic interrogation. | Nat Cancer | 2023 | 37217652 | PubTator, text mining | PubMed |
| Iron metabolism and ferroptosis in diabetic bone loss: from mechanism to therapy. | Front Nutr | 2023 | 37215218 | PubTator, text mining | PubMed |
| Clinical characteristics and outcomes for children, adolescents and young adults with "CIC-fused" or "BCOR-rearranged" soft tissue sarcomas: A multi-institutional European retrospective analysis. | Cancer Med | 2023 | 37212486 | PubTator, text mining | PubMed |
| The phospholipid transporter PITPNC1 links KRAS to MYC to prevent autophagy in lung and pancreatic cancer. | Mol Cancer | 2023 | 37210549 | PubTator, text mining | PubMed |
| Clinical and Pathological Features and Gene Expression Profiles of Clinically Aggressive Papillary Thyroid Carcinomas. | Endocr Pathol | 2023 | 37208504 | PubTator, text mining | PubMed |
| Single-cell atlas of the human neonatal small intestine affected by necrotizing enterocolitis. | PLoS Biol | 2023 | 37205711 | PubTator, text mining | PubMed |
| Celloscope: a probabilistic model for marker-gene-driven cell type deconvolution in spatial transcriptomics data. | Genome Biol | 2023 | 37198601 | PubTator, text mining | PubMed |
| Enzyme-Based Biosensors and Their Applications. | Biosensors (Basel) | 2023 | 37185551 | PubTator, text mining | PubMed |
| Lenvatinib resistance mechanism and potential ways to conquer. | Front Pharmacol | 2023 | 37153782 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1846/papers?page=9